Pharmaceutical Industry: Implementation of Two IT Solutions in Record Time
BRIZ Ltd.
Marketing Authorization Holder & Pharmaceutical Wholesaler BRIZ Ltd. Achieves Compliance with EU Falsified Medicines Directive Within One Month
As of 9 February 2019, all members of the pharmaceutical supply chain are required to implement the EU’s Falsified Medicines Directive to ensure secure labeling of pharmaceutical products.
Arvato Systems and the Latvian pharmaceutical company BRIZ Ltd. agreed several months before the EU FMD came into effect (on 9 February 2019) to quickly implement the Arvato Systems Corporate Serialization Database (Arvato CSDB) solution as well as the Arvato Smart Logistics Platform Healthcare Suite (ASLP Healthcare Suite).
This decision posed a challenge for Arvato Systems: The pharmaceutical marketing authorization holder and its business processes would have to come in line with the requirements of the EU directive within one month.
Ultimately, this was successfully achieved before the deadline set by the EU. As a result, BRIZ Ltd. was able to seamlessly continue with the registration of pharmaceutical products as well as its additional business activities in areas such as wholesale, logistics (including storage), and pharmacovigilance, all in keeping with the provisions of the EU FMD.
Customer Benefits
"We were impressed by the structured and collaborative work from Arvato Systems even though we had a huge time pressure to keep BRIZ productive for the European Market."
About BRIZ Ltd.
BRIZ Ltd. was founded in September 1991 and now offers over 500 different medications and pharmaceutical products. Alongside various MAH licenses, the company also provides services related to registering pharmaceutical products, wholesale, marketing, logistics (including storage), and pharmacovigilance. Europe and Russia constitute its core markets.